For subsequent survival analyses, we found that HCC patients with high expression of CEP55 were more likely to experience a fatal event during the follow-up period, which was consistent among the three cohorts of independent studies of each other (P < 0.05) (Figures 9G–J). Here, CEP55 is linked to hepatocellular carcinoma.